ELK1 is up-regulated by androgen in bladder cancer cells and promotes tumor progression-Reference-Cited by-同舟云学术

ELK1 is up-regulated by androgen in bladder cancer cells and promotes tumor progression

Published:2015-08-22 Issue:30 Volume:6 Page:29860-29876
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Kawahara Takashi¹²³,Shareef Hasanain Khaleel¹⁴,Aljarah Ali Kadhim¹⁵,Ide Hiroki¹,Li Yi²⁶,Kashiwagi Eiji¹,Netto George J.¹,Zheng Yichun¹²⁶,Miyamoto Hiroshi¹²

Affiliation:

1. Departments of Pathology and Urology, Johns Hopkins University School of Medicine, Baltimore, MD, USA

2. Department of Pathology and Laboratory Medicine, University of Rochester Medical Center, Rochester, NY, USA

3. Department of Urology, Yokohama City University School of Medicine, Yokohama, Japan

4. Department of Biology, University of Babylon College of Science for Women, Babylon, Iraq

5. Department of Biology, University of Baghdad College of Science, Baghdad, Iraq

6. Department of Urology, 2nd Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 74 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ELK1/MTOR/S6K1 Pathway Contributes to Acquired Resistance to Gefitinib in Non-Small Cell Lung Cancer;International Journal of Molecular Sciences;2024-02-17

2. Roles of Androgen Receptor Signaling in Urothelial Carcinoma;Cancers;2024-02-10

3. Inhibition of aldo-keto reductase 1C3 overcomes gemcitabine/cisplatin resistance in bladder cancer;Chemico-Biological Interactions;2024-01

4. Mineralocorticoid receptor signaling inhibits bladder cancer progression;American Journal of Cancer Research;2024

5. Expression of PVRL4, a molecular target for cancer treatment, is transcriptionally regulated by FOS;Oncology Reports;2023-12-05